Get started
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.

Daiichi Sankyo Co., Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

DSNKY chart


Full chart

Key stats


Market capitalization
‪43.33 B‬ USD
Dividend yield (indicated)
1.32%
Price to earnings Ratio (TTM)
22.80
Basic EPS (TTM)
1.02 USD
Net income (FY)
‪1.94 B‬ USD
Revenue (FY)
‪12.37 B‬ USD
Shares float
—
Beta (1Y)
0.22

About DAIICHI SANKYO COMPANY LIMITED


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Hiroyuki Okuzawa
Website
daiichisankyo.co.jp
Headquarters
Tokyo
Founded
2005
FIGI
BBG0027W00Q8
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DSNKY news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as DSNKY.